Ten years of treatment with ruxolitinib for myelofibrosis: a review of safetyarticle Published on 2023-07-272024-09-02 Journal: Journal of Hematology & Oncology [Category] 대상포진, [키워드] Janus kinase myelofibrosis myeloproliferative neoplasm ruxolitinib Safety [DOI] 10.1186/s13045-023-01471-z PMC 바로가기 [Article Type] article
Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practicesarticle Published on 2023-03-212024-09-02 Journal: Annals of Hematology [Category] 대상포진, [키워드] Janus kinase myeloproliferative neoplasm polycythemia vera ruxolitinib [DOI] 10.1007/s00277-023-05172-y PMC 바로가기 [Article Type] article
COVID-19 outcomes in patients with cancer: Findings from the University of California health system databaseArticle Published on 2022-06-012023-07-08 Journal: Cancer Medicine [Category] COVID19(2023년), [키워드] Cancer COVID-19 myeloproliferative neoplasm Outcomes research [DOI] 10.1002/cam4.4604 PMC 바로가기
Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registriesArticle Published on 2022-01-102022-10-04 Journal: Scientific Reports [Category] 바이오마커, [키워드] calculated Cancer Comprehensive Epidemiology estimate expected hematological cancer highlight incidence incidence rate leukemia Lineage MDs Myelodysplastic syndrome Myeloproliferative disease myeloproliferative neoplasm neoplasm NOS public health authorities robust Spain Spanish subtype the WHO These data Variability [DOI] 10.1038/s41598-021-03734-6 PMC 바로가기 [Article Type] Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases대뇌 정맥 혈전증 및 골수 증식성 신생물: 74건의 연속 사례에 대한 3개 기관 연구Multicenter Study Published on 2021-12-012022-09-11 Journal: American journal of hematology [Category] 변종, [키워드] age Aspirin association Catholic Central nervous system cerebral CLARITY clinical Clinical features Cognitive impairment conjunction COVID COVID-19 vaccinations Diagnosis essential thrombocythemia feature female gender females Florence Follow-up Frequency headache Headaches hemorrhage highlight include Intracerebral hemorrhage involved likelihood Mayo Clinic median median age myelofibrosis myeloproliferative neoplasm myeloproliferative neoplasms neurological occurred Patient patients polycythemia vera retrospective retrospective review Rome sagittal systemic anticoagulation tested therapy thrombocythemia thrombosis Transverse university vaccination venous Venous thrombosis were recorded with COVID-19 [DOI] 10.1002/ajh.26336 PMC 바로가기 [Article Type] Multicenter Study
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasmsSARS-CoV-2에 대한 BNT162b2 mRNA 백신의 단일 용량은 골수증식성 신생물 환자에서 높은 빈도의 중화 항체 및 다작용성 T 세포 반응을 유도합니다Article Published on 2021-12-012022-09-12 Journal: Leukemia [Category] SARS, 진단, [키워드] dose Frequency induce mRNA vaccine myeloproliferative neoplasm neutralising antibody of BNT162b2 Patient polyfunctional T-cell response SARS-CoV-2 [DOI] 10.1038/s41375-021-01300-7 PMC 바로가기 [Article Type] Article
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccinesSARS-CoV-2 스파이크 단백질 메신저 RNA(mRNA) 백신 접종 후 필라델피아 염색체 양성 또는 음성 골수증식성 신생물이 있는 환자의 혈청 항체 반응Article Published on 2021-12-012022-09-12 Journal: Leukemia [Category] MERS, SARS, 유전자 메커니즘, 진단, [키워드] Antibody Response Messenger RNA mRNA myeloproliferative neoplasm Patient positive SARS-CoV-2 spike protein vaccination Vaccine [DOI] 10.1038/s41375-021-01457-1 PMC 바로가기 [Article Type] Article
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolismCorrespondence Published on 2021-11-292022-10-04 Journal: Blood Cancer Journal [Category] MERS, SARS, 진단, [키워드] COVID-19 patient haematological diseases Infectious diseases myeloproliferative neoplasm Prognosis Risk factors Thrombocytosis Venous Thromboembolism [DOI] 10.1038/s41408-021-00585-2 PMC 바로가기 [Article Type] Correspondence
Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19Conference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 유전자 메커니즘, [키워드] 95% CI Admission age analyzed anticoagulation Aspirin baseline black bleeding blueprint board Boston categorical variable caused clinical clinically CML Cohort cohort analysis Complication consecutive patient constellation continuous variable Corticosteroid COVID COVID-19 critically ill patients D-dimer database death defined diabetes Diagnosis download figure funding General population Health heart failure Hispanic Hispanic ethnicity hospital Hospital admission Hospitalized hospitalized patient hypertension ICU ICU admission identify include Increased increased risk Incyte Infection Infectious disease Inflammatory less leukemia mass Medicine multivariable analysis multivariable logistic regression myelofibrosis myeloproliferative neoplasm Myocardial infarction occurred Older outcome Patient patient population patients PCR PCR testing Philadelphia Platelet polycythemia vera polymerase chain Population positive Primary outcome prognostic readmission Remdesivir required risk risk factor Seattle Sex significantly significantly increased smoking status Society steroid stroke t-test Test tested thrombosis thrombotic complication Thrombotic complications treated Treatment Venous Thromboembolism VTE white with COVID-19 [DOI] 10.1182/blood-2021-151801 [Article Type] Conference abstract
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future ScenariosReview Published on 2021-09-232022-10-31 Journal: Cancers [Category] COVID-19, [키워드] accounted acute respiratory syndrome Cancer challenge China chronic Clinical management Complication coronavirus COVID-19 COVID-19 infection COVID-19 pandemic Efficacy Future Hematological malignancies Hemorrhagic high risk immunosuppressive increased risk Infection information interferon investigated knowledge management MPNs mRNA vaccine myelofibrosis myeloproliferative neoplasm outbreak outcome pandemic Patient Prognosis provided receive reported risk ruxolitinib SARS-CoV2 scenario severe COVID-19 severity of COVID-19 simple syndrome therapy thrombotic thrombotic risk Vaccination strategy Vaccine [DOI] 10.3390/cancers13194750 PMC 바로가기 [Article Type] Review